CVS EBITDA Growth
CVS Health · EBITDA Growth
CVS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.44%period ending
CVS TTM EBITDA YoY % (8.50% → -5.44%)
Year-over-year change
High-resolution chart · PNG
CVS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -5.4365% | |
| -24.8904% | |
| -28.0166% | |
| -25.3574% | |
| -16.6843% | |
| -13.6406% | |
| -24.7184% | |
| -22.7283% | |
| 58.9207% | |
| 41.3092% | |
| 47.7989% | |
| 68.6829% | |
| -39.1559% | |
| -29.8707% | |
| -29.3834% | |
| -36.598% | |
| 3.8339% | |
| 0.2605% | |
| 1.8519% | |
| -5.7895% | |
| -8.6579% | |
| 0.6057% | |
| 4.359% | |
| 31.4026% | |
| 41.6654% | |
| 116.2887% | |
| 143.2597% | |
| 57.1138% | |
| 52.9% | |
| -34.0424% | |
| -42.8995% | |
| -24.513% | |
| -29.2345% | |
| 1.9656% | |
| -3.1255% | |
| -1.4649% | |
| 6.0704% | |
| 0.5366% | |
| 5.386% | |
| 7.3572% | |
| 9.7587% | |
| 13.4848% | |
| 13.1358% | |
| 9.7619% | |
| -0.8579% | |
| 1.2826% | |
| 3.1998% | |
| 4.456% | |
| 12.9279% | |
| 13.4007% | |
| 14.6909% | |
| 12.484% | |
| 11.7527% | |
| 11.8882% | |
| 9.3141% | |
| 11.5315% | |
| 10.1205% | |
| 6.7215% | |
| 3.5377% | |
| -0.5739% | |
| -2.6614% | |
| -4.1355% | |
| -2.5586% | |
| 0.8683% | |
| 2.2708% | |
| 6.4434% | |
| 6.8759% | |
| 9.6516% | |
| 11.7461% | |
| 11.7982% | |
| 24.4671% | |
| 37.5123% | |
| 59.8987% | |
| 94.225% | |
| 85.4515% | |
| 70.5082% | |
| 49.4577% | |
| 26.7046% | |
| 21.709% | |
| 25.1237% | |
| 27.2108% | |
| 28.5427% | |
| 33.6715% | |
| 176.7499% | |
| 169.1343% | |
| 171.9844% | |
| 185.5575% | |
| -47.8858% | |
| -48.2982% | |
| -50.7024% | |
| -54.9357% | |
| 21.2839% | |
| 22.43% | |
| 15.014% | |
| 5.028% | |
| -16.3136% | |
| -22.3526% | |
| -18.9645% | |
| -10.8318% | |
| 3.2653% |